SCHEMBL327612

SCHEMBL327612

CC(C)C1CC1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13089679 1.00
SCHEMBL14963186 1.00
SCHEMBL29034898 1.00
SCHEMBL12986445 1.00
SCHEMBL327613 1.00
SCHEMBL12985951 1.00
SCHEMBL12985560 1.00
SCHEMBL21019458 0.95 SLC1A2 (0.50)
SCHEMBL12763445 0.90 SLC1A2 (0.48)
SCHEMBL25388011 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11732005-B2 Peptidomimetic proteasome inhibitors CORNELL UNIVERSITY (US) 2023-08-22 US disclosed
CN-111819173-B CD73 inhibitors 伊莱利利公司 2023-06-06 CN disclosed
WO-2023014908-A1 LPAR1 ANTAGONISTS AND USES THEREOF Pipeline Therapeutics, Inc. (US) 2023-02-09 WO disclosed
US-20220056073-A1 PEPTIDOMIMETIC PROTEASOME INHIBITORS UNIV CORNELL (US) 2022-02-24 US disclosed
US-11203613-B2 Peptidomimetic proteasome inhibitors CORNELL UNIVERSITY 2021-12-21 US disclosed
US-10968203-B2 Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disorders GENENTECH, INC. (US) 2021-04-06 US disclosed
US-20200317729-A1 PEPTIDOMIMETIC PROTEASOME INHIBITORS CORNELL UNIVERSITY 2020-10-08 US disclosed
EP-3694605-A1 PEPTIDOMIMETIC PROTEASOME INHIBITORS Cornell University (US) 2020-08-19 EP disclosed
CN-111247136-A Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating diseases and disorders associated with IRE1 吉宁特有限公司 2020-06-05 CN disclosed
CN-106502052-B Etching-resistant phenolic aldehyde positive photoresist 潍坊星泰克微电子材料有限公司 2020-01-14 CN disclosed
US-7247725-B2 Gamma-aminoamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-07-24 US disclosed
US-7247725-B2 Gamma-aminoamide modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-07-24 US disclosed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 WO disclosed
US-20070021454-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease MERCK SHARP & DOHME LLC 2007-01-25 US disclosed
US-20070021454-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease MERCK SHARP & DOHME LLC 2007-01-25 US disclosed
US-20070015771-A1 Lonidamine analogs THRESHOLD PHARMACEUTICALS, INC. (US) 2007-01-18 US disclosed
CN-1277796-C Process for the preparation of enantiomerically pure pyrethroid insecticides SYNGENTA LTD (GB) 2006-10-04 CN disclosed
EP-1592661-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES Warner-Lambert Company LLC (US) 2005-11-09 EP disclosed
WO-2004065361-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2004-08-05 WO disclosed
CN-1443153-A Process for preparation of enantiomerically pure pyrethroid insecticides SYNGENTA LTD (GB) 2003-09-17 CN disclosed